Investing Profile

Colleen Cuffaro

VCInvestor
Partner at Canaan Partners
canaan.com/team/colleen-cuffa...New Haven, Connecticut
Photo of Colleen Cuffaro, Partner at Canaan Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Pennsylvania Network
146 CONNECTIONS
Canaan Partners Network
15 CONNECTIONS
cb
$250K - $20.0M
$10.0M
13
$800M
CompanyStageDateRound SizeTotal Raised
Draig Therapeutics
Series AJun 2025$140M
$140M
Co-investors: Liam Ratcliffe (Access Biotechnology)
CatalYm
Series DJul 2024$150M
$200M
Co-investors: Jonathan Tobin (Brandon Capital Partners), Oscar Slotboom (BGV (BioGeneration Ventures)), Nathalie Weitemeyer (Bayern Kapital), Rogier Rooswinkel (Forbion)
AgomAb Therapeutics
Series COct 2023$100M
$200M
Co-investors: Ohad Hammer (Pontifax Venture Capital), Iyona Rajkomar (Pontifax Venture Capital)
RADD Pharmaceuticals
SeedApr 2023
Alphina Therapeutics
Series ASep 2021$40M
$40M
Comet Therapeutics
Series AJun 2019$29M
$29M
Co-investors: Roel Bulthuis (INKEF Capital), Henrijette Richter (Soffinova Partners)
Arrakis Therapeutics
Series BApr 2019$75M
Series AFeb 2017$38M
$110M
Co-investors: Richard Gaster (venBio), Jakob Loven (Nextech Invest)
NextCure
Series BNov 2018$93M
Series AJan 2016$67M
$160M
Co-investors: Tim Shannon (Canaan Partners), David Kabakoff (HealthQuest Capital)
Associate Canaan Partners2014 - Present
Bio Sciences Analyst Entrepreneurship Lab NYC2012 - 2013
Analytical Chemist PMRS Inc2006 - 2009
Yale University School of Medicine PhD Cellular and Molecular Physiology
University of Pennsylvania BA Chemistry